Przejdź do zawartości
· Wypełniacze skórne
SKU 11114

Revanesse Shape™+

Dostępny
Objętość
2 x 1,2 mL
Laboratorium
Prollenium Medical Technologies Inc.
Pochodzenie
Kanada
Wskazanie
Midface, jawline and chin structural support
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Najważniejsze zalety: Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Najważniejsze informacje
Marka REVANESSE
Producent Prollenium Medical Technologies Inc.
Kraj pochodzenia Canada
Certyfikacja CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Skład Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Objętość / Rozmiar 1.2 ml
Opakowanie 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Rozmiar igły 27G, up to two supplied
Rodzaj zastosowania For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Głębokość iniekcji Middle part of the dermis layer
Protokół / Czas trwania Implantation life averages 6 to 12 months, depending on the depth and location of injection

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Medium to deep facial rhytides
  • Lipoatrophy

Zastosowanie profesjonalne

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Obszary zabiegowe

  • Face

Profil pacjenta

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Jak działa Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty REVANESSE od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Więcej od Prollenium Medical Technologies

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Revanesse Shape™+

Dostępny
Oznaczenie CE Oznaczenie CE Revanesse Shape™+
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Najważniejsze zalety: Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Najważniejsze informacje
Marka REVANESSE
Producent Prollenium Medical Technologies Inc.
Kraj pochodzenia Canada
Certyfikacja CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Skład Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Objętość / Rozmiar 1.2 ml
Opakowanie 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Rozmiar igły 27G, up to two supplied
Rodzaj zastosowania For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Głębokość iniekcji Middle part of the dermis layer
Protokół / Czas trwania Implantation life averages 6 to 12 months, depending on the depth and location of injection

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Medium to deep facial rhytides
  • Lipoatrophy

Zastosowanie profesjonalne

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Obszary zabiegowe

  • Face

Profil pacjenta

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Jak działa Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty REVANESSE z pełną identyfikowalnością partii, produktami z certyfikatem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Więcej od Prollenium Medical Technologies

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).